[Treatment of inflammatory diseases in the mouth and pharynx using Imposit].
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D062365:Aminobenzoates / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use*; D002594:Cetylpyridinium / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D005891:Gingivitis / Q000188:drug therapy; D005928:Glossitis / Q000188:drug therapy; D006096:Gramicidin / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy*; D010608:Pharyngeal Diseases / Q000188:drug therapy*; D010612:Pharyngitis / Q000188:drug therapy; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D013281:Stomatitis, Aphthous / Q000188:drug therapy; D014069:Tonsillitis / Q000188:drug therapy
D062365:Aminobenzoates; D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D004338:Drug Combinations; D011726:Pyridinium Compounds; D006096:Gramicidin; D002594:Cetylpyridinium
Zur Behandlung entzündlicher Erkrankungen im Bereich des Mund- and Rachenraums mit Imposit